Schedule 13D ownership disclosure
NEUPHORIA THERAPEUTICS INC
Common Stock, par value $0.00001 per share · CUSIP: 64136E102
Event date: 2025-11-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Lynx1 Capital Management LPReported CIK 0001910456
Shares: 875,328 · Class: 16.3%
- Weston Nichols
Shares: 875,328 · Class: 16.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905148-25-004191
- Form type
- SCHEDULE 13D/A
- Filer
- Lynx1 Capital Management LP
- CIK
- CIK 1910456
- Filed
- Nov 28, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13D beneficial ownership